Wren Laboratories LLC, based in Branford, CT, is a leading molecular diagnostics company specializing in non-invasive liquid biopsy oncology tests. Their suite of proprietary bioanalytics and molecular cancer diagnostics provide oncologists with critical information for real-time diagnosis and treatment decisions. With a focus on detecting molecular biomarkers for cancer, Wren Laboratories offers tests such as NETest, PPQ, and PROSTest, which deliver accurate results and help oncologists better detect and manage various types of cancer.
Utilizing bioinformatic algorithms and liquid biopsy diagnostics, Wren Laboratories precisely characterizes tumor sources and evaluates molecular biomarker gene expression data from blood and saliva samples. Their multi-gene signatures and biomathematical algorithms enable the characterization of a wide range of cancers, including breast, lung, colon, and others. With a mission to enhance pathology and imaging, Wren Laboratories empowers oncologists with knowledge and clarity in cancer diagnoses, enabling them to recommend, manage, and monitor treatment more effectively.
Generated from the website